{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:16:14Z","timestamp":1793373374585,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jaut.2014.01.027","type":"journal-article","created":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T18:00:25Z","timestamp":1393092025000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"special_numbering":"C","title":["Diagnosis and classification of rheumatoid arthritis"],"prefix":"10.1016","volume":"48-49","author":[{"given":"Maria","family":"Kourilovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Galarza-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Ortiz-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.01.027_bib1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.01.027_bib2","series-title":"Copper in medicine and personal care: a historical overview","first-page":"149","author":"Milanino","year":"2006"},{"key":"10.1016\/j.jaut.2014.01.027_bib3","series-title":"A\u00a0treatise on gout and rheumatic gout (rheumatoid arthritis)","author":"Garrod","year":"1876"},{"key":"10.1016\/j.jaut.2014.01.027_bib4","series-title":"The nature and treatment of gout and rheumatic gout (rheumatoid arthritis)","author":"Garrod","year":"1876"},{"key":"10.1016\/j.jaut.2014.01.027_bib5","first-page":"21","article-title":"Rheumatology, past, present and future","volume":"60","author":"Joshi","year":"2012","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.jaut.2014.01.027_bib6","first-page":"289","article-title":"Epigenetic epidemiol","author":"Ospelt","year":"2012"},{"key":"10.1016\/j.jaut.2014.01.027_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","article-title":"The epidemiology of rheumatoid arthritis","volume":"27","author":"Gabriel","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.jaut.2014.01.027_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2012.237","article-title":"Genetics and epigenetics of rheumatoid arthritis","volume":"9","author":"Viatte","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaut.2014.01.027_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10905","article-title":"Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study","volume":"49","author":"Lajas","year":"2003","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaut.2014.01.027_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/ard.52.4.254","article-title":"Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline","volume":"52","author":"Spector","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.01.027_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0049-0172(99)80003-1","article-title":"Rheumatic diseases in North America's indigenous peoples","volume":"28","author":"Peschken","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.01.027_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.34.2.136","article-title":"Rheumatoid arthritis in a rural South African Negro population","volume":"34","author":"Beighton","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.01.027_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.01.027_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0049-0172(97)80012-1","article-title":"Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis","volume":"27","author":"Abdel-Nasser","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.01.027_bib15","first-page":"1009","article-title":"Mortality trends in rheumatoid arthritis: the role of rheumatoid factor","volume":"35","author":"Gonzalez","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2014.01.027_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","article-title":"Comorbidities associated with psoriasis: an experience from the Middle East","volume":"37","author":"Al-Mutairi","year":"2010","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaut.2014.01.027_bib17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.01.027_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","article-title":"Environmental influences on risk for rheumatoid arthritis","volume":"21","author":"Liao","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2014.01.027_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02940.x","article-title":"Early environmental factors and rheumatoid arthritis","volume":"143","author":"Edwards","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.01.027_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/ard.2008.093294","article-title":"Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis","volume":"68","author":"Van Der Kooij","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.01.027_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.22353","article-title":"Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis","volume":"55","author":"Finckh","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaut.2014.01.027_bib22","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.20314","article-title":"Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpo- phalangeal joints of the hands remain normal","volume":"50","author":"Ostendorf","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jaut.2014.01.027_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/art.33348","article-title":"The clinical picture of rheumatoid arthritis according to the 2010 American College of Rheumatology\/European League against Rheumatism criteria: is this still the same disease?","volume":"64","author":"de Hair","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.027_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","article-title":"EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis","volume":"72","author":"Colebatch","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.01.027_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.jaut.2014.01.027_bib26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2014.01.027_bib27","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/ar3546","article-title":"Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study","volume":"13","author":"Yukawa","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2014.01.027_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","article-title":"Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF\u03b1","volume":"64","author":"Eriksson","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.027_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/rheumatology\/kem257","article-title":"Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis","volume":"47","author":"Emery","year":"2008","journal-title":"Rheumatol Oxf"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.027_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10067-013-2213-7","article-title":"Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients","volume":"32","author":"Skare","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.027_bib31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00296-010-1374-9","article-title":"Anticyclic citrullinated peptide autoantibodies in systemic lupus erythematosus","volume":"31","author":"Singh","year":"2011","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.027_bib32","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.090338","article-title":"Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming\/erosive arthritis","volume":"36","author":"Kakumanu","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.027_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-10-29","article-title":"Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis","volume":"10","author":"Tebo","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.027_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jbspin.2012.10.002","article-title":"The relationship between peripheral arthritis and anti-cyclic citrullinated peptide antibodies in ankylosing spondylitis","volume":"80","author":"Kim","year":"2013","journal-title":"Jt Bone Spine"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.027_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/rhu.0000242779.73390.51","article-title":"Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis","volume":"12","author":"Candia","year":"2006","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.027_bib36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3349\/ymj.2012.53.4.759","article-title":"Anti-cyclic citrullinated peptide antibodies and joint involvement in Beh\u00e7et's disease","volume":"53","author":"Cho","year":"2012","journal-title":"Yonsei Med J"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.027_bib37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jbspin.2010.02.013","article-title":"Remittent non-destructive polysynovitis in P-ANCA-positive vasculitis patients with anti-CCP antibodies","volume":"77","author":"Pagnoux","year":"2010","journal-title":"Jt Bone Spine"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.027_bib38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10067-011-1930-z","article-title":"Anti-cyclic citrullinated peptide antibodies in scleroderma patients","volume":"31","author":"Polimeni","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.jaut.2014.01.027_bib39","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1007\/s00296-011-2274-3","article-title":"The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sj\u00f6gren syndrome","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol Int"},{"issue":"13","key":"10.1016\/j.jaut.2014.01.027_bib40","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","article-title":"Distinct phenotypes in mixed connective tissue disease: subgroups and survival","volume":"21","author":"Szodoray","year":"2012","journal-title":"Lupus"},{"issue":"4\u00a0Suppl.\u00a060","key":"10.1016\/j.jaut.2014.01.027_bib41","first-page":"S58","article-title":"Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever","volume":"28","author":"Ceri","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.jaut.2014.01.027_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10067-013-2173-y","article-title":"Antibodies to citrullinated peptides in tuberculosis","volume":"32","author":"Lima","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.jaut.2014.01.027_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.027_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1590\/S0482-50042011000600005","article-title":"Anti-citrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection","volume":"51","author":"Ahlin","year":"2011","journal-title":"Rev Bras Reumatol"},{"issue":"11","key":"10.1016\/j.jaut.2014.01.027_bib45","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1007\/s00296-011-2224-0","article-title":"Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico","volume":"32","author":"Zavala-Cerna","year":"2012","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.027_bib46","first-page":"57","article-title":"Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis","volume":"22","author":"Riccio","year":"2008","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"issue":"6","key":"10.1016\/j.jaut.2014.01.027_bib47","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3899\/jrheum.100713","article-title":"Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection","volume":"38","author":"Du Toit","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2014.01.027_bib48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/IOP.0b013e3181c70c2e","article-title":"Anticyclic-citrullinated protein antibodies in the diagnosis of ophthalmic inflammatory disease","volume":"27","author":"Wladis","year":"2011","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.jaut.2014.01.027_bib49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/jcpe.12138","article-title":"Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres","volume":"40","author":"Lappin","year":"2013","journal-title":"J\u00a0Clin Periodontol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.027_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00296-012-2458-5","article-title":"The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern turkey","volume":"33","author":"Tasliyurt","year":"2013","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.027_bib51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.berh.2011.10.009","article-title":"Co-morbidities in established rheumatoid arthritis","volume":"25","author":"Gullick","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5 Suppl.\u00a031","key":"10.1016\/j.jaut.2014.01.027_bib52","first-page":"S154","article-title":"Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention","volume":"21","author":"Quinn","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.jaut.2014.01.027_bib53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.01.027_bib54","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1136\/annrheumdis-2013-203842","article-title":"Systemic literature review of the performance of the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance","volume":"72","author":"Zeidler","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.01.027_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2013.06.008","article-title":"Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment?","volume":"13","author":"Caporali","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.01.027_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2012.05.021","article-title":"Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction","volume":"39","author":"Boissier","year":"2012","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:07:39Z","timestamp":1760256459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":56,"alternative-id":["S0896841114000304"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.01.027","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and classification of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}